Moderate Associations Between the Use of Levonorgestrel-releasing Intrauterine Device and Metabolomics Profile
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae318 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Elena Toffol und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Clinicum, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland. Hauptthemen laut MEDLINE: Levonorgestrel, Intrauterine Devices, Medicated, Contraceptive Agents, Female, Metabolome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jane and Aatos Erkko Foundation, Finnish Cultural Foundation.
Abstract (Originalsprache)
Context
Use of a levonorgestrel-releasing intrauterine device (LNG-IUD) has become common irrespective of age and parity. To date, only a few studies have examined its possible metabolic changes and large-scale biomarker profiles in detail and in a longitudinal design.
Objective
To apply the metabolomics technique to examine the metabolic profile associated with the use of LNG-IUD both in a cross-sectional and a longitudinal design.
Design
The study consists of cross-sectional and longitudinal analyses of a population-based survey (Health 2000) and its 11-year follow-up (Health 2011). All participants aged 18 to 49 years with available information on hormonal contraceptive use and metabolomics data (n = 1767) were included. Altogether 212 metabolic measures in LNG-IUD users (n = 341) were compared to those in non-users of hormonal contraception (n = 1426) via multivariable linear regression models. Participants with complete longitudinal information (n = 240) were divided into continuers, stoppers, starters, and never-user groups, and 11-year changes in levels of each metabolite were compared.
Results
After adjustment for covariates, levels of 102 metabolites differed in LNG-IUD current users compared to non-users of hormonal contraception (median difference in biomarker concentration: –0.12 SD): lower levels of fatty acids concentrations and ratios, cholesterol, triglycerides and other lipids, as well as particle concentration, cholesterol, total lipids, and phospholipids in lipoproteins. The 11-year metabolic changes did not differ in relation to changes in LNG-IUD use.
Conclusion
The use of LNG-IUD was associated with several moderate metabolic changes, mostly suggestive of a reduced arterial cardiometabolic risk. Changes in LNG-IUD use were not related to long-term metabolic changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health, Clinicum, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
- Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00014 Helsinki, Finland.
- Department of Public Health and Welfare, Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland.
- Department of Knowledge Brokers, Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland.
- Department of Government Services, Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland.
ORCID-Profile: Elena Toffol, Oskari Heikinheimo, Lara Lehtoranta, Anni Joensuu, Timo Partonen, Iris Erlund, Jari Haukka
Förderung
- Jane and Aatos Erkko Foundation
- Finnish Cultural Foundation
Zitieren
APA
Toffol, E., Heikinheimo, O., Jousilahti, P., Lehtoranta, L., Joensuu, A., Partonen, T., Erlund, I., & Haukka, J. (2025). Moderate Associations Between the Use of Levonorgestrel-releasing Intrauterine Device and Metabolomics Profile. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae318
Vancouver
Toffol E, Heikinheimo O, Jousilahti P, Lehtoranta L, Joensuu A, Partonen T, et al. Moderate Associations Between the Use of Levonorgestrel-releasing Intrauterine Device and Metabolomics Profile. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae318
BibTeX
@article{Toffol2025,
author = {Toffol, Elena and Heikinheimo, Oskari and Jousilahti, Pekka and Lehtoranta, Lara and Joensuu, Anni and Partonen, Timo and Erlund, Iris and Haukka, Jari},
title = {Moderate Associations Between the Use of Levonorgestrel-releasing Intrauterine Device and Metabolomics Profile},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae318}
}
EUVIMED